Hemostemix, Inc. (HEM.V)
0.055
0.00 (0.00%)
CAD |
TSXV |
May 29, 16:00
Hemostemix Total Liabilities (Quarterly) : 5.897M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Microbix Biosystems, Inc. | 10.22M |
| Helix BioPharma Corp. | 3.164M |
| Sernova Biotherapeutics, Inc. | 26.62M |
| Covalon Technologies Ltd. | 5.162M |
| Medicenna Therapeutics Corp. | 6.853M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.4254M |
| Shareholders Equity (Quarterly) | -5.472M |
| Debt to Equity Ratio | -0.6609 |
| Current Ratio | 0.2371 |
| Net Debt Paydown Yield | 2.08% |